CY2024 Q3
| Company | Value | End Date | SEC Filing |
|---|---|---|---|
| BRISTOL-MYERS SQUIBB COMPANY | $324,000,000.00 | 2024-09-30 | View |
| 1st FRANKLIN FINANCIAL CORPORATION | $263,071,104.00 | 2024-09-30 | View |
| HUMANA INC | $400,000,000.00 | 2024-09-30 | View |
| PACKAGING CORP OF AMERICA | $69,700,000.00 | 2024-09-30 | View |
| PFIZER INC | $6,000,000.00 | 2024-09-29 | View |
| Sysco Corporation | $114,000,000.00 | 2024-09-28 | View |
| SEI INVESTMENTS COMPANY | $175,722,000.00 | 2024-09-30 | View |
| Micron Technology, Inc. | $1,046,000,000.00 | 2024-08-29 | View |
| U S GLOBAL INVESTORS INC | $3,742,000.00 | 2024-09-30 | View |
| SB FINANCIAL GROUP, INC. | $600,000.00 | 2024-09-30 | View |
| MITEK SYSTEMS, INC. | $11,410,000.00 | 2024-09-30 | View |
| Starbucks Corporation | $276,000,000.00 | 2024-09-29 | View |
| BioLife Solutions, Inc. | $4,884,000.00 | 2024-09-30 | View |
| HCA Healthcare, Inc. | $553,000,000.00 | 2024-09-30 | View |
| IONIS PHARMACEUTICALS, INC. | $689,946,000.00 | 2024-09-30 | View |
| Asure Software, Inc. | $61,455,000.00 | 2024-09-30 | View |
| GERON CORP | $37,312,000.00 | 2024-09-30 | View |
| VERICEL CORPORATION | $32,895,000.00 | 2024-09-30 | View |
| NEKTAR THERAPEUTICS | $4,537,000.00 | 2024-09-30 | View |
| Urban Outfitters, Inc. | $240,237,000.00 | 2024-10-31 | View |
| NEUROCRINE BIOSCIENCES, INC. | $643,900,000.00 | 2024-09-30 | View |
| ERIE INDEMNITY COMPANY | $1,000,282,000.00 | 2024-09-30 | View |
| Azenta, Inc. | $49,454,000.00 | 2024-09-30 | View |
| TRINET GROUP, INC. | $145,000,000.00 | 2024-09-30 | View |
| ASTROTECH Corp | $0.00 | 2024-09-30 | View |
| BioMarin Pharmaceutical Inc | $561,985,000.00 | 2024-09-30 | View |
| F5, INC. | $0.00 | 2024-09-30 | View |
| CYTOKINETICS, INCORPORATED | $269,168,000.00 | 2024-09-30 | View |
| Akamai Technologies, Inc | $255,108,000.00 | 2024-09-30 | View |
| DEXCOM, INC. | $217,300,000.00 | 2024-09-30 | View |
| ALIGN TECHNOLOGY, INC. | $0.00 | 2024-09-30 | View |
| NiSource Inc. | $137,900,000.00 | 2024-09-30 | View |
| Tapestry, Inc | $0.00 | 2024-09-28 | View |
| GARMIN LTD | $1,106,532,000.00 | 2024-09-28 | View |
| LIQUIDMETAL TECHNOLOGIES INC | $6,368,000.00 | 2024-09-30 | View |
| ELEVANCE HEALTH, INC. | $893,000,000.00 | 2024-09-30 | View |
| CARDIFF ONCOLOGY, INC. | $8,844,000.00 | 2024-09-30 | View |
| GLOBUS MEDICAL, INC. | $12,297,000.00 | 2024-09-30 | View |
| LegalZoom.com, Inc. | $1,386,000.00 | 2024-09-30 | View |
| TURNING POINT BRANDS, INC. | $4,372,000.00 | 2024-09-30 | View |
| AEROVIRONMENT, INC. | $760,000.00 | 2024-10-26 | View |
| ANAPTYSBIO, INC | $27,914,000.00 | 2024-09-30 | View |
| ETSY, INC | $107,046,000.00 | 2024-09-30 | View |
| SERVICENOW, INC. | $3,829,000,000.00 | 2024-09-30 | View |
| Rapid Micro Biosystems, Inc. | $0.00 | 2024-09-30 | View |
| HubSpot, Inc. | $165,623,000.00 | 2024-09-30 | View |
| EchoStar Corporation | $39,291,000.00 | 2024-09-30 | View |
| Olo Inc. | $42,140,000.00 | 2024-09-30 | View |
| ZEVRA THERAPEUTICS, INC. | $6,105,000.00 | 2024-09-30 | View |
| TRAVERE THERAPEUTICS, INC. | $22,084,000.00 | 2024-09-30 | View |
| AGIOS PHARMACEUTICALS, INC. | $655,889,000.00 | 2024-09-30 | View |
| ARBUTUS BIOPHARMA CORP | $2,964,000.00 | 2024-09-30 | View |
| ADAPTIVE BIOTECHNOLOGIES CORPORATION | $23,866,000.00 | 2024-09-30 | View |
| MACOM Technology Solutions Holdings, Inc. | $150,603,000.00 | 2024-09-27 | View |
| ULTRAGENYX PHARMACEUTICAL INC. | $203,086,000.00 | 2024-09-30 | View |
| SPROUT SOCIAL, INC. | $0.00 | 2024-09-30 | View |
| Alkermes plc. | $18,775,000.00 | 2024-09-30 | View |
| Guidewire Software, Inc. | $142,119,000.00 | 2024-10-31 | View |
| Aclaris Therapeutics, Inc. | $45,714,000.00 | 2024-09-30 | View |
| INTRA-CELLULAR THERAPIES, INC. | $164,000,000.00 | 2024-09-30 | View |
| Oscar Health, Inc. | $1,933,892,000.00 | 2024-09-30 | View |
| MURPHY USA INC. | $0.00 | 2024-09-30 | View |
| Acumen Pharmaceuticals, Inc. | $58,552,000.00 | 2024-09-30 | View |
| MARCUS & MILLICHAP, INC. | $50,208,000.00 | 2024-09-30 | View |
| SENTINELONE, INC | $440,381,000.00 | 2024-10-31 | View |
| Atea Pharmaceuticals, Inc. | $0.00 | 2024-09-30 | View |
| BLUEPRINT MEDICINES CORPORATION | $148,180,000.00 | 2024-09-30 | View |
| Inspire Medical Systems, Inc. | $113,425,000.00 | 2024-09-30 | View |
| Caribou Biosciences, Inc. | $52,837,000.00 | 2024-09-30 | View |
| Cogent Biosciences, Inc. | $10,029,000.00 | 2024-09-30 | View |
| Stoke Therapeutics, Inc. | $29,952,000.00 | 2024-09-30 | View |
| SNOWFLAKE INC. | $892,777,000.00 | 2024-10-31 | View |
| UroGen Pharma Ltd. | $4,641,000.00 | 2024-09-30 | View |
| FULGENT GENETICS, INC. | $602,232,000.00 | 2024-09-30 | View |
| Moderna, Inc. | $2,335,000,000.00 | 2024-09-30 | View |
| PRAXIS PRECISION MEDICINES, INC. | $54,141,000.00 | 2024-09-30 | View |
| iQIYI, Inc. | $101,199,000.00 | 2024-09-30 | View |
| Arcus Biosciences, Inc. | $2,000,000.00 | 2024-09-30 | View |
| SEER, INC. | $64,894,000.00 | 2024-09-30 | View |
| Allogene Therapeutics, Inc. | $111,821,000.00 | 2024-09-30 | View |
| Mirum Pharmaceuticals, Inc. | $9,321,000.00 | 2024-09-30 | View |
| ROOT, INC. | $266,200,000.00 | 2024-09-30 | View |
| DOORDASH, INC. | $795,000,000.00 | 2024-09-30 | View |
| ORIC PHARMACEUTICALS, INC. | $9,998,000.00 | 2024-09-30 | View |
| CLOVER HEALTH INVESTMENTS, CORP. /DE | $184,085,000.00 | 2024-09-30 | View |
| SKILLZ INC. | $0.00 | 2024-09-30 | View |
| Royalty Pharma plc | $657,300,000.00 | 2024-09-30 | View |
| NAUTILUS BIOTECHNOLOGY, INC. | $80,618,000.00 | 2024-09-30 | View |
| Orchestra BioMed Holdings, Inc. | $5,600,000.00 | 2024-09-30 | View |
| Abacus Life, Inc. | $1,185,740.00 | 2024-09-30 | View |
| KYMERA THERAPEUTICS, INC. | $361,035,000.00 | 2024-09-30 | View |
| TOURMALINE BIO, INC. | $32,467,000.00 | 2024-09-30 | View |
| NET Power Inc. | $18,411,000.00 | 2024-09-30 | View |
| CANTOR EQUITY PARTNERS, INC. | $100,804,997.00 | 2024-09-30 | View |
SEC Filings Explorer
Formalu provides easy access to SEC filings and reporting data
Most Recent Filings
2000 most recent SEC filings for the current official filing date
Browse By Company
All SEC filings and reported GAAP facts from 2010 to now for every company
Formalu's Securities and Exchange Commission Page
SEC forms, contact information and locations